Suppr超能文献

塞尔维亚肺结核患者中耐多药结核病的危险因素:一项病例对照研究。

Risk factors for multidrug-resistant tuberculosis among tuberculosis patients in Serbia: a case-control study.

机构信息

Department of HIV/AIDS, STIs, Viral Hepatitis and TB, Public Health Institute of Serbia, "Dr Milan Jovanovic Batut", Dr Subotica 5, Belgrade, 11000, Serbia.

Institute of Social Medicine, Faculty of Medicine, Belgrade University, Dr Subotica 9, Belgrade, 11000, Serbia.

出版信息

BMC Public Health. 2018 Sep 12;18(1):1114. doi: 10.1186/s12889-018-6021-5.

Abstract

BACKGROUND

Multidrug resistant (MDR) tuberculosis (TB) represents TB which is simultaneous resistant to at least rifampicin (R) and isoniazid (H). Identifying inadequate therapy as the main cause of this form of the disease and explaining the factors leading to its occurrence, numerous social determinants that affect the risk of developing resistance are highlighted. The objectives of the study was to identify independent factors of MDR-TB among tuberculosis patients.

METHODS

Case-control study was conducted from 1st September 2009 to 1st June 2014 in 31 healthcare institutions in Serbia where MDR-TB and TB patients were treated. TB patients infected with MDR- M. tuberculosis and non MDR- M. tuberculosis strain were considered as cases and controls, respectively. Cases and controls were matched by the date of hospitalization. The data was collected using structured questionnaire with face to face interview. Bivariate and multivariable logistic regression analysis (MLRA) were used to identify determinants associated with MDR-TB.

RESULTS

A total of 124 respondents, 31 cases and 93 controls were participated in the study. MLRA identified six significant independent risk factors for the occurrence of MDR-TB as follows: monthly income of the family (Odds ratio (OR) = 3.71; 95% Confidence Interval (CI) = 1.22-11.28), defaulting from treatment (OR = 3.33; 95% CI = 1.14-9.09), stigma associated with TB (OR = 2.97; 95% CI = 1.18-7.45), subjective feeling of sadness (OR = 4.05; 95% CI = 1.69-9.70), use of sedatives (OR = 2.79; 95% CI = 1.02-7.65) and chronic obstructive pulmonary disease (OR = 4.51; 95% CI = 1.07-18.96).

CONCLUSION

In order to reduce burden of drug resistance, strategies of controlling MDR-TB in Serbia should emphasize multi-sectorial actions, addressing health care and social needs of TB patients.

摘要

背景

耐多药结核病(MDR-TB)是指同时对利福平(R)和异烟肼(H)至少具有耐药性的结核病。确定治疗不足是导致这种形式疾病的主要原因,并解释导致其发生的因素,突出了影响耐药风险的众多社会决定因素。本研究的目的是确定结核病患者中 MDR-TB 的独立因素。

方法

这是一项病例对照研究,于 2009 年 9 月 1 日至 2014 年 6 月 1 日在塞尔维亚的 31 家医疗机构进行,在这些机构中治疗了 MDR-TB 和结核病患者。感染耐多药-M. tuberculosis 和非耐多药-M. tuberculosis 菌株的结核病患者分别被视为病例和对照。病例和对照按住院日期匹配。使用面对面访谈的结构化问卷收集数据。使用二变量和多变量逻辑回归分析(MLRA)来确定与 MDR-TB 相关的决定因素。

结果

共有 124 名受访者,31 名病例和 93 名对照参加了这项研究。MLRA 确定了发生 MDR-TB 的六个显著独立危险因素,如下所示:家庭月收入(优势比(OR)=3.71;95%置信区间(CI)=1.22-11.28)、治疗中断(OR=3.33;95%CI=1.14-9.09)、与结核病相关的耻辱感(OR=2.97;95%CI=1.18-7.45)、主观悲伤感(OR=4.05;95%CI=1.69-9.70)、使用镇静剂(OR=2.79;95%CI=1.02-7.65)和慢性阻塞性肺疾病(OR=4.51;95%CI=1.07-18.96)。

结论

为了降低耐药负担,塞尔维亚控制 MDR-TB 的策略应强调多部门行动,满足结核病患者的医疗和社会需求。

相似文献

1
Risk factors for multidrug-resistant tuberculosis among tuberculosis patients in Serbia: a case-control study.
BMC Public Health. 2018 Sep 12;18(1):1114. doi: 10.1186/s12889-018-6021-5.
2
Risk factors for multidrug resistant tuberculosis patients in Amhara National Regional State.
Afr Health Sci. 2015 Jun;15(2):368-77. doi: 10.4314/ahs.v15i2.9.
4
Predictor of multidrug resistant tuberculosis in southwestern part of Ethiopia: a case control study.
Ann Clin Microbiol Antimicrob. 2018 Jul 3;17(1):30. doi: 10.1186/s12941-018-0283-8.
6
Assessment of the risk factors associated with multidrug-resistant tuberculosis in Sudan: a case-control study.
Epidemiol Health. 2019;41:e2019014. doi: 10.4178/epih.e2019014. Epub 2019 Apr 20.
10
Risk factors for multidrug-resistant tuberculosis in Hong Kong.
Int J Tuberc Lung Dis. 2008 Sep;12(9):1065-70.

引用本文的文献

2
Sociodemographic determinants of multidrug-resistant tuberculosis in Lesotho: A case-control study.
PLOS Glob Public Health. 2025 Jul 10;5(7):e0004075. doi: 10.1371/journal.pgph.0004075. eCollection 2025.
3
Risk factors for multidrug-resistant tuberculosis: a predictive model study.
Front Med (Lausanne). 2024 Sep 27;11:1410690. doi: 10.3389/fmed.2024.1410690. eCollection 2024.
4
Drug resistance profiles of clinical isolates by genotype MTBDRplus line probe assay in Zambia: findings and implications.
JAC Antimicrob Resist. 2024 Jul 25;6(4):dlae122. doi: 10.1093/jacamr/dlae122. eCollection 2024 Aug.
6
Prevalence and risk factors of anxiety and depression in patients with multi-drug/rifampicin-resistant tuberculosis.
Front Public Health. 2024 Mar 27;12:1372389. doi: 10.3389/fpubh.2024.1372389. eCollection 2024.
7
Distribution of multi-drug resistant tuberculosis in Ekiti and Ondo states, Nigeria.
New Microbes New Infect. 2023 Oct 31;55:101192. doi: 10.1016/j.nmni.2023.101192. eCollection 2023 Oct.
8
Ongoing Healthcare Disparities in neuroHIV: Addressing Gaps in the Care Continuum.
Curr HIV/AIDS Rep. 2023 Dec;20(6):368-378. doi: 10.1007/s11904-023-00683-9. Epub 2023 Nov 24.
9
Rifampicin resistant and associated factors among presumptive pulmonary tuberculosis patients in Mogadishu, Somalia.
SAGE Open Med. 2023 Jan 10;11:20503121221148603. doi: 10.1177/20503121221148603. eCollection 2023.

本文引用的文献

1
Effect of Brazil's conditional cash transfer programme on tuberculosis incidence.
Int J Tuberc Lung Dis. 2017 Jul 1;21(7):790-796. doi: 10.5588/ijtld.16.0599.
2
Determinants of tuberculosis transmission and treatment abandonment in Fortaleza, Brazil.
BMC Public Health. 2017 May 25;17(1):508. doi: 10.1186/s12889-017-4435-0.
3
Prevalence and risk factors of multi-drug resistant tuberculosis in Dalian, China.
J Int Med Res. 2017 Dec;45(6):1779-1786. doi: 10.1177/0300060516687429. Epub 2017 Mar 27.
4
Risk factors for multidrug-resistant tuberculosis among tuberculosis patients: a case-control study.
Infect Drug Resist. 2017 Mar 13;10:91-96. doi: 10.2147/IDR.S126274. eCollection 2017.
5
Development of a Patient-Centred, Psychosocial Support Intervention for Multi-Drug-Resistant Tuberculosis (MDR-TB) Care in Nepal.
PLoS One. 2017 Jan 18;12(1):e0167559. doi: 10.1371/journal.pone.0167559. eCollection 2017.
8
Determinants of multidrug-resistant tuberculosis in Henan province in China: a case control study.
BMC Public Health. 2016 Jan 16;16:42. doi: 10.1186/s12889-016-2711-z.
9
Association between spending on social protection and tuberculosis burden: a global analysis.
Lancet Infect Dis. 2016 Apr;16(4):473-9. doi: 10.1016/S1473-3099(15)00401-6. Epub 2015 Dec 23.
10
Prognostic factors of treatment among patients with multidrug-resistant tuberculosis in Egypt.
J Formos Med Assoc. 2016 Nov;115(11):997-1003. doi: 10.1016/j.jfma.2015.10.002. Epub 2015 Dec 13.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验